Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2

J Virol. 2004 Oct;78(20):11429-33. doi: 10.1128/JVI.78.20.11429-11433.2004.

Abstract

Replication of viruses in species other than their natural hosts is frequently limited by entry and postentry barriers. The coronavirus that causes severe acute respiratory syndrome (SARS-CoV) utilizes the receptor angiotensin-converting enzyme 2 (ACE2) to infect cells. Here we compare human, mouse, and rat ACE2 molecules for their ability to serve as receptors for SARS-CoV. We found that, compared to human ACE2, murine ACE2 less efficiently bound the S1 domain of SARS-CoV and supported less-efficient S protein-mediated infection. Rat ACE2 was even less efficient, at near background levels for both activities. Murine 3T3 cells expressing human ACE2 supported SARS-CoV replication, whereas replication was less than 10% as efficient in the same cells expressing murine ACE2. These data imply that a mouse transgenically expressing human ACE2 may be a useful animal model of SARS.

Publication types

  • Comparative Study

MeSH terms

  • 3T3 Cells
  • Animals
  • Cell Line
  • Endopeptidases / metabolism*
  • Humans
  • Mice
  • Peptidyl-Dipeptidase A / metabolism*
  • Rats
  • Severe Acute Respiratory Syndrome / virology
  • Severe acute respiratory syndrome-related coronavirus / pathogenicity
  • Severe acute respiratory syndrome-related coronavirus / physiology*
  • Virus Replication*

Substances

  • Endopeptidases
  • Peptidyl-Dipeptidase A
  • angiotensin-producing serum enzyme II